1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Multiple Sclerosis, Secondary Progressive: new trials by email Literature Review of Multiple Sclerosis, Secondary Progressive trials Research Report on Multiple Sclerosis, Secondary Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis Masitinib, Placebo - Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive | Phase 3 | Completed | AB Science | 656 | 2011-08-01 | 2020-04-08 |
Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Chronic Disease (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
masitinib (1)
AB Science (1)
Bulgaria (1) · France (1) · Germany (1) · Greece (1) · Poland (1) · Romania (1) · Spain (1)
Patrick Vermersch, MD, PhD (1)